INS and atherosclerosis: In this regard, it would be interesting to determine whether a prolonged WD-CO treatment would maintain its protective effects on atherosclerosis, or it would worsen systemic and tissue-specific inflammation, leading to development of hepatic injury and other metabolic dysfunctions such as insulin resistance.